Endo Pharmaceuticals Financial Statements
Endo Pharmaceuticals Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
© 2009 Morningstar, Inc. Financial Data provided by
Endo Pharmaceuticals Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,260.5 | 1,085.6 | 909.7 |
| Gross Profit ($ mil.) | 993.3 | 868.2 | 708.2 |
| Operating Income ($ mil.) | 410.6 | 353.4 | -- |
| Total Net Income ($ mil.) | 261.7 | 227.4 | 137.8 |
| Diluted EPS (Net Income) | 2.12 | 1.69 | 1.03 |
Endo Pharmaceuticals Quarterly Statements
| Quarter Ending Sep 09 | Quarter Ending Jun 09 | Quarter Ending Jun 09 | |
|---|---|---|---|
| Revenue ($ mil.) | 361.0 | 373.1 | 373.1 |
| Gross Profit ($ mil.) | 263.7 | 278.0 | 278.0 |
| Operating Income ($ mil.) | -- | -- | -- |
| Total Net Income ($ mil.) | 49.4 | 30.0 | 30.0 |
| Diluted EPS (Net Income) | 0.42 | 0.26 | 0.26 |
Endo Pharmaceuticals Stock Quote & Chart
11/06/09 16:00:02 EST •
NASDAQ •
23.00
•
 +0.1100
•
+0.4806 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Endo Pharmaceuticals Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1.90 | 16.45 | 7.01 |
| Price/Earnings Ratio | 13.64 | 384.62 | 25.51 |
| Price/Book Ratio | 2.01 | 3.53 | 6.74 |
| Price/Cash Flow Ratio | 7.76 | 80.00 | 43.48 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Endo Pharmaceuticals Financial Ratios
Endo Pharmaceuticals Competitive Intelligence
| Abbott Labs | Johnson & Johnson | King Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 29,527.6 | 63,747.0 | 1,565.1 |
| Employees | 69,000 | 118,700 | 3,392 |
| Market Cap ($ mil.) | 79,660.8 | 166,373.7 | 2,781.6 |
Competitive Landscape
